Advanced company searchLink opens in new window

SPERO CANTAB UK LIMITED

Company number 10175336

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
30 Sep 2024 AA Total exemption full accounts made up to 31 December 2023
22 May 2024 CS01 Confirmation statement made on 10 May 2024 with no updates
30 Aug 2023 AA Total exemption full accounts made up to 31 December 2022
22 May 2023 CS01 Confirmation statement made on 10 May 2023 with no updates
03 May 2023 AD03 Register(s) moved to registered inspection location 5th Floor Halo Counterslip Bristol BS1 6AJ
03 May 2023 AD02 Register inspection address has been changed to 5th Floor Halo Counterslip Bristol BS1 6AJ
29 Sep 2022 AA Total exemption full accounts made up to 31 December 2021
06 Jun 2022 CS01 Confirmation statement made on 10 May 2022 with no updates
07 Oct 2021 AA Total exemption full accounts made up to 31 December 2020
10 May 2021 CS01 Confirmation statement made on 10 May 2021 with no updates
20 Nov 2020 AA Total exemption full accounts made up to 31 December 2019
21 May 2020 CS01 Confirmation statement made on 10 May 2020 with updates
11 Nov 2019 TM01 Termination of appointment of Joel Sendek as a director on 8 November 2019
07 Oct 2019 AA Group of companies' accounts made up to 31 December 2018
13 May 2019 CS01 Confirmation statement made on 10 May 2019 with updates
15 Apr 2019 TM01 Termination of appointment of Stephen Garbacz as a director on 15 April 2019
15 Apr 2019 AP01 Appointment of Mr Joel Sendek as a director on 15 April 2019
08 Nov 2018 AA Total exemption full accounts made up to 31 December 2017
03 Aug 2018 CH01 Director's details changed for Stephen Garbacz on 3 August 2018
03 Aug 2018 CH01 Director's details changed for Ankit Atul Mahadevia on 3 August 2018
03 Aug 2018 CH01 Director's details changed for Stephen Garbacz on 3 August 2018
14 May 2018 PSC02 Notification of Spero Therapeutics, Inc. as a person with significant control on 13 June 2017
14 May 2018 PSC09 Withdrawal of a person with significant control statement on 14 May 2018
14 May 2018 CS01 Confirmation statement made on 10 May 2018 with updates
04 Oct 2017 AA Total exemption full accounts made up to 31 December 2016